柠檬酸三锂盐四水合物 T0256
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
500 mg | 6080-58-6 | ¥99.00 | 询底价 |
1 mL | 6080-58-6 | ¥150.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Citric acid trilithium salt tetrahydrate
描述: Citric acid trilithium salt tetrahydrate (Lithium citrate tribasic tetrahydrate) 是一种用于治疗精神疾病的药物。它也是一种医药和建筑材料, 可用于氨基酸定量分析时的梯度洗脱。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 52 mg/mL (184.4 mM)
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
H2O : 51 mg/mL (180.9 mM)
关键字: HIF-1α | HIF-PH | Lithium citrate tribasic Tetrahydrate | Citrate | CaOx | ACLY | ATP Citrate Lyase | HIF/HIF Prolyl-Hydroxylase | Citric acid trilithium salt tetrahydrate | Litarex tetrahydrate | Trilithium citrate Tetrahydrate | HIFs | Lithium citrate tetrahydrate | cleavage | Bacterial | Hypoxia-inducible factors | Lithium citrate tribasic | stones | extramitochondrial | antioxidation | Citric acid trilithium Tetrahydrate | Trilithium Citrate | inhibit | ATP | Inhibitor | anti-inflammation | Citric acid | safety
相关产品: AZD8329 | Ammonium Glycyrrhizinate | Perfluorooctanoic acid | Vidofludimus | CPS-11 | Isovaleramide | BI-187004 | CB29 | ALDH1A3-IN-3 | Trilostane
相关库: Anti-Neurodegenerative Disease Compound Library | Drug Repurposing Compound Library | FDA-Approved Kinase Inhibitor Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Anti-infective Natural Product Library
柠檬酸三锂盐四水合物 T0256信息由TargetMol中国为您提供,如您想了解更多关于柠檬酸三锂盐四水合物 T0256报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途